NIVALIS THERAPEUTICS INC's ticker is NVLS and the CUSIP is 65481J109. A total of 26 filers reported holding NIVALIS THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $35,000 | – | 14,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,709,673 | $13,900,000 | 2.62% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,732,412 | $30,345,000 | 1.41% |
| TIGER MANAGEMENT L.L.C. | 650,915 | $5,292,000 | 1.25% |
| WALL STREET ASSOCIATES | 170,400 | $1,385,000 | 0.47% |
| SPHERA FUNDS MANAGEMENT LTD. | 204,700 | $1,664,000 | 0.27% |
| Endurant Capital Management LP | 85,412 | $694,000 | 0.26% |
| Rock Springs Capital Management LP | 489,000 | $3,976,000 | 0.25% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 541,700 | $4,404,000 | 0.20% |
| TLP GROUP LLC | 11,150 | $91,000 | 0.10% |
| DAFNA Capital Management LLC | 15,000 | $122,000 | 0.08% |